Metagenomi Therapeutics, Inc. (MGX)
1.71
+0.08
(+4.91%)
USD |
NASDAQ |
Jan 22, 10:12
Metagenomi Therapeutics EPS Diluted (Quarterly): -0.546 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.805 |
| AnaptysBio, Inc. | 0.5208 |
| Ovid Therapeutics, Inc. | -0.171 |
| Nutriband, Inc. | -0.3212 |
| Cogent Biosciences, Inc. | -0.5884 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.39M |
| Revenue (Quarterly) | 8.659M |
| Total Expenses (Quarterly) | 29.05M |
| Enterprise Value | -81.25M |
| Gross Profit Margin (Quarterly) | 84.71% |
| Profit Margin (Quarterly) | -235.5% |
| Earnings Yield | -139.4% |
| Normalized Earnings Yield | -130.16 |